KRRO
Sign in
Frequency Therapeutics Inc
Save
409.11M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases.
Similar securities
Based on sector and market capitalization
Report issue